ReviewCureus2025

Comparative Efficacy of Ublitixumab Versus Natalizumab in the Treatment of Relapsing and Remitting Multiple Sclerosis.

Sai V Chitturi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.